Skip to content
WorldBrand.AI

Buchang Pharmaceutical controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2019

    Chairman's family embroiled in U.S. college admissions fraud controversy

    In 2019, media reported that the family of Zhao Tao, chairman of Buchang Pharmaceuticals, paid US$6.5 million through an admissions intermediary, and his daughter was admitted to Stanford before her enrollment was revoked. Zhao Tao responded that the source of funds for studying abroad was unrelated to the listed company. This entry concerns a personal controversy involving the chairman's family; the cited reports did not find that Zhao Tao was criminally convicted or misappropriated company funds.

    Source